TheProfitWatch

APRE - Aprea Therapeutics, Inc. Common stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
1.51 0.05 (3.6%) --- 0.0 (0.0%) 0.03 (2.25%) 0.0 (0.0%) -0.02 (-1.32%) 0.03 (2.25%) 0.03 (2.25%)

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

Category: PHARMACEUTICAL PREPARATIONS
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.53
Diluted EPS:
-0.53
Basic P/E:
-2.9517
Diluted P/E:
-2.9517
RSI(14) 1m:
100.0
VWAP:
1.56
RVol:
2.4704

Events

Period Kind Movement Occurred At
1m Price decrease 1m 1.49 -0.02 (-1.32%) Oct 15 09:44

Related News